English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1386]
News [2627]
Articles [25]
Editorials [0]
Conferences [150]
elearning [15]
ASCO 2022: Gut microbiome signatures associated with immunotherapy response in glioblastoma
ASCO 2022: Gut microbiome signatures associated with immunotherapy response in glioblastoma
Four multinational, interdisciplinary teams selected to address major challenges in cancer
Four multinational, interdisciplinary teams selected to address major challenges in cancer
Mechanical transmission enables EMT cancer cells to drive epithelial cancer cell migration to guide tumour spheroid disaggregation
Mechanical transmission enables EMT cancer cells to drive epithelial cancer cell migration to guide tumour...
Researchers contribute to discovery of mechanism leading to drug resistance in prostate cancer
Researchers contribute to discovery of mechanism leading to drug resistance in prostate cancer
Researchers discover genes that predict good response to blood cancer therapy
Researchers discover genes that predict good response to blood cancer therapy
Androgen receptor signaling contributes to targeted therapy resistance in melanoma
Androgen receptor signaling contributes to targeted therapy resistance in melanoma
Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers
Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers
High-intensity focused ultrasound can control prostate cancer with fewer side effects
High-intensity focused ultrasound can control prostate cancer with fewer side effects
How diet and the microbiome affect colorectal cancer
How diet and the microbiome affect colorectal cancer
Molecule that combines three distinct technologies against most aggressive type of brain cancer is tested
Molecule that combines three distinct technologies against most aggressive type of brain cancer is tested
<1...100101102103104...263>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top